Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Patricia McKnight

    News

    Better monitoring of cisplatin-induced ototoxicity needed

    Author:
    Patricia McKnight
    Publish date: April 28, 2023

    “Providing treating oncologists with a timely opportunity to alter therapy or providing patients with support, guidance, and earlier access to...

    • Read More

    News

    Prostate cancer drug shortage leaves some with uncertainty

    Author:
    Patricia McKnight
    Publish date: March 22, 2023

    The therapy lutetium Lu 177 vipivotide tetraxetan will remain in limited supply until the drug’s manufacturer can ramp up production.

    • Read More

    News

    Silicone-based film for radiation dermatitis: It works, so why isn’t it used?

    Author:
    Patricia McKnight
    Publish date: March 13, 2023

    Use of the film significantly reduced the incidence of grade 2 or 3 radiation dermatitis in a study of women with breast cancer.

    • Read More

    News

    FDA expands abemaciclib use in high-risk early breast cancer

    Author:
    Patricia McKnight
    Publish date: March 7, 2023

    The new expansion removes the Ki-67 testing requirement.

    • Read More

    News

    Efanesoctocog alfa treatment: ‘Victory’ over hemophilia A

    Author:
    Patricia McKnight
    Publish date: February 27, 2023

    In a phase 3 study of patients with severe hemophilia A, a new factor VIII injection given weekly prevented almost all bleeding episodes.

    • Read More

    News

    Black patients less likely to receive opioids for advanced cancer

    Author:
    Patricia McKnight
    Publish date: February 3, 2023

    Black patients were more likely to undergo urine drug screening despite being less likely to receive any opioids for pain management.

    • Read More

    News

    Difficulty fitting family into career: Female oncologists

    Author:
    Patricia McKnight
    Publish date: January 31, 2023

    In a survey of female oncologists, 95% said their career plans were at least somewhat associated with the timing of when to start a family.

    • Read More

    News

    FDA OKs zanubrutinib for CLL or SLL

    Author:
    Patricia McKnight
    Publish date: January 20, 2023

    Zanubrutinib for treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma has been greenlighted by the FDA.

    • Read More

    News

    Health risks low for children exposed in utero to cancer and chemo

    Author:
    Patricia McKnight
    Publish date: January 13, 2023

    Treatment decisions should take into account the diagnosis and prognosis of the mother, the gestational age of the fetus, and the potential...

    • Read More

    News

    Study of beliefs about what causes cancer sparks debate

    Author:
    Patricia McKnight
    Publish date: January 3, 2023

    The authors set out to evaluate “the patterns of beliefs about cancer among people who believed in conspiracies, rejected the COVID-19 vaccine, or...

    • Read More

    News

    Multiple myeloma diagnosed more via emergency care during COVID

    Author:
    Patricia McKnight
    Publish date: December 19, 2022

    While trying to avoid COVID-19 infection, patients ultimately diagnosed with multiple myeloma may have delayed interactions with healthcare...

    • Read More

    News

    Link between PCOS and increased risk of pancreatic cancer?

    Author:
    Patricia McKnight
    Publish date: November 7, 2022

    “These data suggest some individuals may have unknown metabolic derangements that may underlie the development of both conditions.”

    • Read More

    News

    FDA OKs selpercatinib for adults with RET-fusion+ solid tumors

    Author:
    Patricia McKnight
    Publish date: September 23, 2022

    In 2020, selpercatinib received accelerated approval for lung and thyroid RET-positive tumors.

    • Read More

    News

    FDA OKs sodium thiosulfate injection to reduce ototoxicity risk in children with cancer

    Author:
    Patricia McKnight
    Publish date: September 22, 2022

    “Historically, there have been no approved treatments for preventing cisplatin-induced hearing loss.”

    • Read More

    News

    Date with adult model leads to testicular cancer diagnosis

    Author:
    Patricia McKnight
    Publish date: September 7, 2022

    Ms. Grace suggests that sexual intimacy offers an opportunity for noting physical changes.

    • Read More

    Pages

    • « first
    • 1
    • 2

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery